As we observe Rare Disease Day today, let us take a look at seven drugs poised to be approved to address rare diseases in ...

This useful study presents findings on the developmental roles of Nup107, a key nucleoporin, in regulating the larval-to-pupal transition in Drosophila melanogaster through its involvement in ecdysone ...

Cancer therapy has advanced with molecularly targeted approaches and immunotherapy, yet chemotherapy remains essential for ...

Shah and colleagues take advantage of the presence of maternal and somatic ribosomes in zebrafish and confirm their differential expression during development. The authors convincingly show that ...

Professor Moore says the risk factors for cirrhosis often emerge in our 20s and it generally takes 20 years to develop, ‘so ...

The companies Eikon Therapeutics, Sionna Therapeutics, and Abcuro bagged the biggest biotech funding rounds overall in ...

Tuberculosis remains one of the most lethal infectious diseases caused by a single pathogen. According to the latest global ...

Food allergy, intolerance, and sensitivity generally differ based on whether or not IgE, a protein the body can make against ...

Blood clotting disorders can be inherited or acquired. Some types cause excessive bleeding, while others cause excessive ...

For most, an evening around the dinner table is a perfect way to wind down with friends and family. But for 24-year-old Annie ...

The FDA approved the investigational new drug application for a phase 1 trial of ADCE-T02 in advanced solid tumors.

Announced acceptance and Priority Review by the United States Food and Drug Administration (FDA) of the new drug application (NDA) for troriluzole in all-genotype spinocerebellar ataxia; expected ...